Korro Bio, Inc. (KRRO)
9.44
+0.53
(+5.95%)
USD |
NASDAQ |
Oct 20, 16:00
9.44
0.00 (0.00%)
After-Hours: 06:22
Korro Bio EPS Diluted (Quarterly) : -1.074 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.074 |
| March 31, 2026 | -1.692 |
| December 31, 2025 | -5.321 |
| September 30, 2025 | -1.923 |
| June 30, 2025 | -2.744 |
| March 31, 2025 | -2.492 |
| December 31, 2024 | -2.261 |
| September 30, 2024 | -2.257 |
| June 30, 2024 | -2.429 |
| March 31, 2024 | -2.439 |
| December 31, 2023 | -4.892 |
| September 30, 2023 | -65.08 |
| June 30, 2023 | -63.83 |
| March 31, 2023 | -72.20 |
| Date | Value |
|---|---|
| December 31, 2022 | -24.62 |
| September 30, 2022 | -27.73 |
| June 30, 2022 | -30.43 |
| March 31, 2022 | -33.59 |
| December 31, 2021 | -31.07 |
| September 30, 2021 | -36.51 |
| June 30, 2021 | -25.78 |
| March 31, 2021 | -29.86 |
| December 31, 2020 | -15.13 |
| September 30, 2020 | -8.074 |
| June 30, 2020 | -9.697 |
| March 31, 2020 | -7.958 |
| December 31, 2019 | -8.969 |
| September 30, 2019 | -2.581 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.92M |
| Total Expenses (Quarterly) | 18.92M |
| Enterprise Value | 66.00M |
| Earnings Yield | -106.0% |
| Normalized Earnings Yield | -78.82 |